Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Oxford University Press
2016
|